2023 annual financial data
Mirum Pharmaceuticals 2023 Operating margin
Mirum Pharmaceuticals 2023 operating margin with verified reported values.
Direct answer
Operating margin was -58.57%.
Operating income was -109,154,000 USD and net income was -163,415,000 USD.
Operating cash flow was -70,944,000 USD.
Get free Mirum Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 186,374,000 USD
- Operating income
- -109,154,000 USD
- Net income
- -163,415,000 USD
- Operating cash flow
- -70,944,000 USD